HNB
PTLA

Huntington National Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Huntington National Bank’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40
Closed -$2K – 1726
2017
Q4 		$2K Hold
40
– – ﹤0.01% 1589
2017
Q3 		$2K Hold
40
– – ﹤0.01% 1571
2017
Q2 		$2K Hold
40
– – ﹤0.01% 1481
2017
Q1 		$2K Hold
40
– – ﹤0.01% 1372
2016
Q4 		$0 Hold
40
– – ﹤0.01% 1552
2016
Q3 		$1K Buy
+40
New +$939 ﹤0.01% 1500

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Huntington National Bank's PTLA Position: Q1 2018 in Review

Huntington National Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2018, closing a stake of 40 shares — an estimated $2K sold.

Huntington National Bank first reported a position in PTLA in Q3 2016 and held it in 6 quarters. The position peaked at $2K in Q4 2017. 180 funds tracked by Wall St. Rank hold PTLA as of Q1 2018.

  • Huntington National Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Huntington National Bank sold 40 Portola Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2K.
  • Huntington National Bank first reported a position in Portola Pharmaceuticals, Inc. in Q3 2016 and held it in 6 quarters.
  • Huntington National Bank's Portola Pharmaceuticals, Inc. position peaked at $2K in Q4 2017.
  • 180 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2018.

Based on Huntington National Bank's 13F filing for Q1 2018, filed 30 Apr 2018.